Hugh Mostafid
- Co-authors
- Luca AfferiYair LotanSima P. PortenMarco MoschiniShilpa GuptaNiyati LoboSarah P. PsutkaAngela B. Smith
- Topics
- Bladder and Urothelial Cancer Treatments (24 papers)Urinary and Genital Oncology Studies (15 papers)Urological Disorders and Treatments (8 papers)
- Partner nations
- United KingdomNetherlandsItaly
In The Last Decade
Hugh Mostafid
25 papers receiving 342 citations
Hit Papers
Peers
Comparison fields: 5 of 49
- Surgery 274
- Urology 85
- Molecular Biology 79
- Oncology 69
- Pulmonary and Respiratory Medicine 63
Countries citing papers authored by Hugh Mostafid
This map shows the geographic impact of Hugh Mostafid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Mostafid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Mostafid more than expected).
Fields of papers citing papers by Hugh Mostafid
This network shows the impact of papers produced by Hugh Mostafid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Mostafid. The network helps show where Hugh Mostafid may publish in the future.
Co-authorship network of co-authors of Hugh Mostafid
This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Mostafid. A scholar is included among the top collaborators of Hugh Mostafid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Mostafid. Hugh Mostafid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Epidemiology, Screening, and Prevention of Bladder Cancerbreakdown → | 159 |
| 2 | 43 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 28 | |
| 6 | 17 | |
| 7 | 3 | |
| 8 | 10 | |
| 9 | 24 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 5 | |
| 15 | 7 | |
| 16 | 1 | |
| 17 | HYMN: a randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of BCG or institutional standard in patients with recurrence of non-muscle invasive bladder cancer (NMIBC) following induction or maintenance BCG therapy | 3 |
| 18 | 5 | |
| 19 | 17 | |
| 20 | 1 |
About Hugh Mostafid
Hugh Mostafid is a scholar working on Urology, Biotechnology and Surgery, having authored 26 papers that have together received 345 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (24 papers), Urinary and Genital Oncology Studies (15 papers) and Urological Disorders and Treatments (8 papers). The work is most often cited by research in Urology (85 citations), Surgery (274 citations) and Oncology (69 citations). Hugh Mostafid has collaborated with scholars based in United Kingdom, Netherlands and Italy. Frequent co-authors include Luca Afferi, Yair Lotan, Sima P. Porten, Marco Moschini, Shilpa Gupta, Niyati Lobo, Sarah P. Psutka, Angela B. Smith, Stephen B. Williams and Nikhil Mayor. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.